跳至主要内容
临床试验/CTRI/2020/05/025180
CTRI/2020/05/025180已完成未知

Inj. Ferric Carboxymaltose (FCM) Vs Iron Isomaltoside (IIM) in anemia in Pregnancy (Antenatal)- A Randomized controlled trial

Bhawna Garg0 个研究点目标入组 140 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Antepartum women whose Hemoglobin is in range of 7 to 10.9 gram per decilitre
  • Women in second trimester of pregnancy (14- to 22 weeks)

排除标准

  • Women not willing to participate
  • Women with less than 14 weeks of gestation
  • Women in labor
  • Known case of Thalassemia or Megaloblastic anemia
  • Women who have a history or known allergy to parenteral iron infusion.
  • Women with normal serum ferritin levels
  • history of any liver disease
  • history of any Autoimmune disease

研究者

发起方
Bhawna Garg

相似试验